Liabilities and Equity of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Liabilities and Equity for the quarter ending 31 Dec 2024 was $4,623,704, a 38% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$4,623,704	+$1,271,922	+38%	31 Dec 2024	20-F	13 Jun 2025	2024	FY
Q4 2023	$3,351,782	+$1,246,929	+59%	31 Dec 2023	20-F/A	23 Sep 2025	2023	FY
Q3 2023	$1,797,722			30 Sep 2023	6-K	13 Nov 2023	2023	Q3
Q4 2022	$2,104,853	-$1,158,185	-35%	31 Dec 2022	20-F/A	23 Sep 2025	2023	FY
Q4 2021	$3,263,038	+$437,327	+15%	31 Dec 2021	20-F	15 May 2023	2022	FY
Q4 2020	$2,825,711			31 Dec 2020	20-F	15 May 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.